Activist investor Ananym plans to start proxy fight at Henry Schein - Reuters

Activist investor Ananym plans to start proxy fight at Henry Schein - Reuters
Henry Schein to acquire Acentus
Henry Schein extends gain on report of activist stake, push for board changes
Henry Schein picks up majority stake in Large Practice Sales
Henry Schein acquires Regional Health Care Group
Henry Schein to acquire S.I.N. Implant System, Brazil
9.67BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8064071025
CUSIP
806407102
Sector
Healthcare
Industry
Medical Distribution
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
25.25
PEG Ratio
1.69
Book Value
28.21
Dividend Share
-
Dividend Yield
-
Earnings Share
3.43
Wall Street Target Price
96.87
EPS Estimate Current Year
5.39
EPS Estimate Next Year
5.99
EPS Estimate Current Quarter
1.2388
EPS Estimate Next Quarter
1.3604
Most Recent Quarter
-
Revenue TTM
13,601,999,872
Gross Profit TTM
4,260,000,000
EBITDA
1,080,000,000
Profit Margin
2.96%
Return On Assets TTM
4.39%
Return On Equity TTM
8.85%
Revenue Per Share TTM
116.771
Qtly Revenue Growth YOY
6.70%
Diluted Eps TTM
3.43
Qtly Earnings Growth YOY
17.10%
Trailing PE
25.25
Forward PE
14
Price Sales TTM
0.7254
Price Book MRQ
2.9964
Enterprise Value Revenue
0
Enterprise Value EBITDA
12
342.00
1.29%10.58
0.86%22.68
0.00%20.09
0.00%7.09
0.00%1.90
0.00%2.06
-4.19%1.21
-3.20%995.10
-0.71%252.87
-0.70%